Publicacións (14)

¹ Publicaciones consideradas como producción de la unidad.

Ver datos de investigación referenciados.

no ano 2023 Eliminar o filtro
filter_list Desde o ano 2023 Ata o ano 2023 Cancer Research

2023

  1. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

    Genome Medicine, Vol. 15, Núm. 1

  2. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

    Cancer Medicine, Vol. 12, Núm. 15, pp. 16142-16162

  3. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

    Journal of Clinical Oncology, Vol. 41, Núm. 10, pp. 1849-1863

  4. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

    Journal of Medical Genetics, Vol. 60, Núm. 12, pp. 1186-1197

  5. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

    Nature Genetics, Vol. 55, Núm. 9, pp. 1435-1439

  6. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

    Diabetologia, Vol. 66, Núm. 8, pp. 1481-1500

  7. Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer

    Bladder Cancer, Vol. 9, Núm. 2, pp. 141-150

  8. Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

    JNCI Cancer Spectrum, Vol. 7, Núm. 6

  9. Radiation Therapy for Metastatic Lung Cancer: Bone Metastasis and Metastatic Spinal Cord Compression

    Medical Radiology (Springer Science and Business Media Deutschland GmbH), pp. 779-793

  10. Radiogenomics in lung cancer: Where are we?

    Lung Cancer, Vol. 176, pp. 56-74

  11. Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

    Cancers, Vol. 15, Núm. 13

  12. Stereotactic body radiation therapy for kidney cancer. Where do we stand?

    International Journal of Urology, Vol. 30, Núm. 5, pp. 437-445

  13. The impact of coding germline variants on contralateral breast cancer risk and survival

    American Journal of Human Genetics, Vol. 110, Núm. 3, pp. 475-486

  14. Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review

    Future oncology (London, England), Vol. 19, Núm. 25, pp. 1753-1768